- Home
- ADTN vs XNCR Comparison
ADTN vs XNCR Comparison
Compare ADTN & XNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADTN
- XNCR
- Stock Information
- Founded
- ADTN 1985
- XNCR 1997
- Country
- ADTN United States
- XNCR United States
- Employees
- ADTN N/A
- XNCR N/A
- Industry
- ADTN Telecommunications Equipment
- XNCR Biotechnology: Pharmaceutical Preparations
- Sector
- ADTN Telecommunications
- XNCR Health Care
- Exchange
- ADTN Nasdaq
- XNCR Nasdaq
- Market Cap
- ADTN 657.1M
- XNCR 579.3M
- IPO Year
- ADTN 1994
- XNCR 2013
- Fundamental
- Price
- ADTN $7.91
- XNCR $8.54
- Analyst Decision
- ADTN Strong Buy
- XNCR Buy
- Analyst Count
- ADTN 4
- XNCR 7
- Target Price
- ADTN $12.00
- XNCR $27.50
- AVG Volume (30 Days)
- ADTN 771.5K
- XNCR 855.3K
- Earning Date
- ADTN 08-04-2025
- XNCR 08-04-2025
- Dividend Yield
- ADTN N/A
- XNCR N/A
- EPS Growth
- ADTN N/A
- XNCR N/A
- EPS
- ADTN N/A
- XNCR N/A
- Revenue
- ADTN $944,291,000.00
- XNCR $127,228,000.00
- Revenue This Year
- ADTN $13.90
- XNCR N/A
- Revenue Next Year
- ADTN $9.13
- XNCR $28.84
- P/E Ratio
- ADTN N/A
- XNCR N/A
- Revenue Growth
- ADTN N/A
- XNCR N/A
- 52 Week Low
- ADTN $4.62
- XNCR $7.16
- 52 Week High
- ADTN $12.44
- XNCR $27.24
- Technical
- Relative Strength Index (RSI)
- ADTN 48.48
- XNCR 44.94
- Support Level
- ADTN $7.42
- XNCR $8.05
- Resistance Level
- ADTN $7.87
- XNCR $10.20
- Average True Range (ATR)
- ADTN 0.30
- XNCR 0.57
- MACD
- ADTN -0.02
- XNCR -0.01
- Stochastic Oscillator
- ADTN 42.89
- XNCR 31.40
About ADTN ADTRAN Holdings Inc.
Adtran Holdings Inc is a provider of networking and communications platforms, software, and services focused on the broadband access market. It operates under two reportable segments: Network Solutions, which includes hardware and software products that enable a digital future that supports the company's Subscriber, Access & Aggregation, and Optical Networking Solutions; and Services & Support Segment which includes network design, implementation, maintenance and cloud-hosted services supporting the company's Subscriber, Access & Aggregation, and Optical Networking Solutions.
About XNCR Xencor Inc.
Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.